Phathom Pharmaceuticals shares owned by Rhumbline Advisers
Quarter-by-quarter ownership of Phathom Pharmaceuticals (PHAT) shares owned by Rhumbline Advisers
from 13F filings
Historical chart of Rhumbline Advisers investment in Phathom Pharmaceuticals
Tip: Access up to 7 years of quarterly data
All positions including Phathom Pharmaceuticals held by Rhumbline Advisers consolidated in one spreadsheet with up to 7 years of data
Download as csv Download as ExcelQuarterly reported holdings in Phathom Pharmaceuticals by Rhumbline Advisers
Quarter filed | Position value | Share count | Share price at filing |
---|---|---|---|
2024-09-30 | $920k | 51k | 18.08 |
2024-06-30 | $568k | 55k | 10.30 |
2024-03-31 | $500k | 47k | 10.62 |
2023-12-31 | $443k | 49k | 9.13 |
2023-09-30 | $586k | 57k | 10.37 |
2023-06-30 | $719k | 50k | 14.32 |
2023-03-31 | $234k | 33k | 7.14 |
2022-12-31 | $345k | 31k | 11.23 |
2022-09-30 | $321k | 29k | 11.10 |
2022-06-30 | $225k | 27k | 8.44 |
2022-03-31 | $272k | 20k | 13.62 |
2021-12-31 | $338k | 17k | 19.64 |
2021-09-30 | $560k | 18k | 32.08 |
2021-06-30 | $556k | 16k | 33.82 |
2021-03-31 | $428k | 11k | 37.58 |
2020-12-31 | $405k | 12k | 33.20 |
2020-09-30 | $400k | 11k | 36.63 |
2020-06-30 | $421k | 13k | 32.92 |
2020-03-31 | $295k | 11k | 25.83 |
2019-12-31 | $218k | 7.0k | 31.21 |